| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |